Revolution’s pancreatic cancer drug wins speedy FDA approval

The U.S. FDA has approved Revolution Medicines’ groundbreaking pancreatic cancer drug after it was shown to double the survival rate of patients with advanced disease in a large trial, offering new ​hope to those with the deadly cancer.